Pancreatic Cancer Research

ResearcherSeoul National UniversityActive in the last 2 years

Dong‐Chan Oh

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-6405-5535; OpenAlex author ID A5000424971. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
12
Papers, trials and grants by year

2024: 1 paper · 2025: none · 2026: 1 paper

Papers 2

  1. Metabologenomic Hallmark-Based Discovery of Bacterial Thioamides as a New Lead against Drug-Resistant Pancreatic Cancer. Last author DOI 10.1002/advs.202517849↗
  2. Antiproliferative Activity of Piceamycin by Regulating Alpha-Actinin-4 in Gemcitabine-Resistant Pancreatic Cancer Cells. Co-author DOI 10.4062/biomolther.2023.109↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sang Kook Lee · 2 shared papers, 2024–2026 · strength 0.42
  2. Young Eun Du · 1 shared paper, 2026 · strength 0.23
  3. Eun Seo Bae · 1 shared paper, 2026 · strength 0.23
  4. Woo Hyun Paik · 1 shared paper, 2024 · strength 0.18
  5. In Rae Cho · 1 shared paper, 2024 · strength 0.18
  6. J.H. Lee · 1 shared paper, 2024 · strength 0.18
  7. Ja‐Lok Ku · 1 shared paper, 2024 · strength 0.18
  8. Sang Hyub Lee · 1 shared paper, 2024 · strength 0.18
  9. Jin Ho Choi MD · 1 shared paper, 2024 · strength 0.18
  10. Min Woo Lee · 1 shared paper, 2024 · strength 0.18
  11. Ji Kon Ryu · 1 shared paper, 2024 · strength 0.18
  12. Yong‐Tae Kim · 1 shared paper, 2024 · strength 0.18

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.